Business Standard

Tuesday, December 24, 2024 | 11:26 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Outcome of board meeting of Camlin Fine Sciences

Image

Capital Market

Held on 12 May 2015

Camlin Fine Sciences announced that the Board of Directors of the Company at its meeting held on 12 May 2015, inter alia, has approved the following:

1. Re-appointment of Ashish S. Dandekar as a Managing Director of the Company for a period of 3 years w.e.f. 01 August 2015, subject to the approval of shareholders at the ensuing Annual General Meeting of the Company.

2. Acquisition of land admeasuring 64,407.91 square meters and setting up a manufacturing facility for Hydroquinone/ Catechol and its down steam products Guaiacol and Vanillin at Dahej Sez, Bharuch District, Gujarat.

3. Setting up a wholly owned subsidiary Company in Mexico for undertaking trading and distribution of Antioxidants, food ingredients, Blends, Formulations, feeds, performance chemicals etc in Central American markets.

 

4. Setting up a wholly owned subsidiary Company in China for undertaking trading and distribution of Antioxidants, food ingredients, Blends, Formulations, feeds, performance chemicals etc in Chinese markets.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 13 2015 | 7:20 AM IST

Explore News